Synonyms: Gantanol® | RO 4-2130 | RO-42130 | SMX | STX-608
sulfamethoxazole is an approved drug (FDA (1965))
Compound class:
Synthetic organic
Comment: Sulfamethoxazole is a sulfonamide antibacterial that has bacteriostatic activity. It inhibits the bacterial dihydropteroate synthase pathway which generates the folic acid that is essential for bacterial growth. It is active against Gram-negative and Gram-positive bacteria including Listeria monocytogenes and E. coli.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use |
Sulfamethoxazole is used to treat bacterial urinary tract infections, bronchitis, and prostatitis. It is principally used in combination with trimethoprim (SMX-TMP, Co-Trimoxazole). Co-Trimoxazole is authorised for use in the UK. SMX-TMP is on the WHO Model List of Essential medicines as a first-line medicine for urinary tract infections. |
External links |
For extended ADME data see the following: Drugs.com |